Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Human defensin alpha-1 causes Trypanosoma cruzi membrane pore formation and induces DNA fragmentation, which leads to trypanosome destruction.

Madison MN, Kleshchenko YY, Nde PN, Simmons KJ, Lima MF, Villalta F.

Infect Immun. 2007 Oct;75(10):4780-91. Epub 2007 Jul 16.

2.

Cellular response to Trypanosoma cruzi infection induces secretion of defensin α-1, which damages the flagellum, neutralizes trypanosome motility, and inhibits infection.

Johnson CA, Rachakonda G, Kleshchenko YY, Nde PN, Madison MN, Pratap S, Cardenas TC, Taylor C, Lima MF, Villalta F.

Infect Immun. 2013 Nov;81(11):4139-48. doi: 10.1128/IAI.01459-12. Epub 2013 Aug 26.

3.

Effects of human defensin-α(1)on Trypanosoma cruzi trypomastigotes in vitro.

Kleschenko YE, Karpenko LP, Villalta F.

Bull Exp Biol Med. 2010 Nov;149(6):731-3.

4.

Parasiticidal activity of human alpha-defensin-5 against Toxoplasma gondii.

Tanaka T, Rahman MM, Battur B, Boldbaatar D, Liao M, Umemiya-Shirafuji R, Xuan X, Fujisaki K.

In Vitro Cell Dev Biol Anim. 2010 Jun;46(6):560-5. doi: 10.1007/s11626-009-9271-9. Epub 2010 Feb 5.

PMID:
20135360
5.

4-Nitrobenzaldehyde thiosemicarbazone: a new compound derived from S-(-)-limonene that induces mitochondrial alterations in epimastigotes and trypomastigotes of Trypanosoma cruzi.

Britta EA, Scariot DB, Falzirolli H, da Silva CC, Ueda-Nakamura T, Dias Filho BP, Borsali R, Nakamura CV.

Parasitology. 2015 Jun;142(7):978-88. doi: 10.1017/S0031182015000141. Epub 2015 Feb 25.

PMID:
25711881
6.
7.

Effects of a marine serine protease inhibitor on viability and morphology of Trypanosoma cruzi, the agent of Chagas disease.

de Almeida Nogueira NP, Morgado-Díaz JA, Menna-Barreto RF, Paes MC, da Silva-López RE.

Acta Trop. 2013 Oct;128(1):27-35. doi: 10.1016/j.actatropica.2013.05.013. Epub 2013 Jun 11.

PMID:
23770204
8.

The marsupial trypanosome Trypanosoma copemani is not an obligate intracellular parasite, although it adversely affects cell health.

Cooper C, Andrew Thompson RC, Rigby P, Buckley A, Peacock C, Clode PL.

Parasit Vectors. 2018 Sep 20;11(1):521. doi: 10.1186/s13071-018-3092-1.

9.
10.

Effect of Crotalus viridis viridis snake venom on the ultrastructure and intracellular survival of Trypanosoma cruzi.

Adade CM, Cons BL, Melo PA, Souto-Padrón T.

Parasitology. 2011 Jan;138(1):46-58. doi: 10.1017/S0031182010000958. Epub 2010 Jul 21.

PMID:
20663246
11.
12.

Host cell actin remodeling in response to Trypanosoma cruzi: trypomastigote versus amastigote entry.

Mortara RA, Andreoli WK, Fernandes MC, da Silva CV, Fernandes AB, L'Abbate C, da Silva S.

Subcell Biochem. 2008;47:101-9. Review.

PMID:
18512345
13.

Trypanosoma cruzi trypomastigotes induce cytoskeleton modifications during HeLa cell invasion.

Fernandes MC, Andrade LR, Andrews NW, Mortara RA.

Mem Inst Oswaldo Cruz. 2011 Dec;106(8):1014-6. Erratum in: Mem Inst Oswaldo Cruz. 2012 Feb;107(1). doi: 10.1590/S0074-02762012000100022.

14.

Molecular cloning of a Trypanosoma cruzi cell surface casein kinase II substrate, Tc-1, involved in cellular infection.

Augustine SA, Kleshchenko YY, Nde PN, Pratap S, Ager EA, Burns JM Jr, Lima MF, Villalta F.

Infect Immun. 2006 Jul;74(7):3922-9.

15.

From lysosomes into the cytosol: the intracellular pathway of Trypanosoma cruzi.

Andrews NW.

Braz J Med Biol Res. 1994 Feb;27(2):471-5.

PMID:
8081267
16.

Mammalian cell invasion and intracellular trafficking by Trypanosoma cruzi infective forms.

Mortara RA, Andreoli WK, Taniwaki NN, Fernandes AB, Silva CV, Fernandes MC, L'Abbate C, Silva Sd.

An Acad Bras Cienc. 2005 Mar;77(1):77-94. Epub 2005 Feb 2. Review.

18.

Trypanosoma cruzi: infection of T lymphocytes and their destruction by antibody-dependent cell-mediated cytotoxicity.

Velge P, Kusnierz JP, Ouaissi A, Marty B, Pham BN, Capron A.

Eur J Immunol. 1991 Sep;21(9):2145-52.

PMID:
1909643
19.

Altering the motility of Trypanosoma cruzi with rabbit polyclonal anti-peptide antibodies reduces infection to susceptible mammalian cells.

Finkelsztein EJ, Diaz-Soto JC, Vargas-Zambrano JC, Suesca E, Guzmán F, López MC, Thomas MC, Forero-Shelton M, Cuellar A, Puerta CJ, González JM.

Exp Parasitol. 2015 Mar;150:36-43. doi: 10.1016/j.exppara.2015.01.007. Epub 2015 Jan 26.

PMID:
25633439
20.

Primary evidence of the mechanisms of action of HIV aspartyl peptidase inhibitors on Trypanosoma cruzi trypomastigote forms.

Sangenito LS, Menna-Barreto RFS, Oliveira AC, d'Avila-Levy CM, Branquinha MH, Santos ALS.

Int J Antimicrob Agents. 2018 Aug;52(2):185-194. doi: 10.1016/j.ijantimicag.2018.03.021. Epub 2018 Apr 7.

PMID:
29635008

Supplemental Content

Support Center